These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 941954)
1. The effects of norgestrel on carbohydrate and lipid metabolism over one year. Spellacy WN; Buhi WC; Birk SA Am J Obstet Gynecol; 1976 Aug; 125(7):984-6. PubMed ID: 941954 [TBL] [Abstract][Full Text] [Related]
2. Effects of daily 30 MCG norgestrel on glucose, insulin, cholesterol and triglycerides during 1 year's time of use. Boonsiri B; Virutamasen P; Tangkeo P; Wongsrichanalai C Asia Oceania J Obstet Gynaecol; 1983 Jun; 9(2):180-4. PubMed ID: 6351820 [TBL] [Abstract][Full Text] [Related]
3. Prospective studies of carbohydrate metabolism in "normal" women using norgestrel for eighteen months. Spellacy WN; Buhi WC; Birk SA Fertil Steril; 1981 Feb; 35(2):167-71. PubMed ID: 7009219 [TBL] [Abstract][Full Text] [Related]
4. Oral contraception, mechanical contraception, and carbohydrate and lipid metabolism: a two-year study. Pribicevic V; Skrabalo Z; Lipovac V; Trenc S; Zadjelovic J; Rajkovic Z Int J Fertil; 1979; 24(2):114-9. PubMed ID: 40904 [TBL] [Abstract][Full Text] [Related]
5. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499 [TBL] [Abstract][Full Text] [Related]
6. Norgestrel and carbohydrate-lipid metabolism: glucose, insulin and triglyceride changes during six months time of use. Spellacy WN; Buhi WC; Birk SA Contraception; 1974 Jun; 9(6):615-25. PubMed ID: 4448088 [No Abstract] [Full Text] [Related]
7. Carbohydrate and lipid metabolic studies before and after one year of treatment with ethynodiol diacetate in "normal" women. Spellacy WN; Buhi WC; Birk SA Fertil Steril; 1976 Aug; 27(8):900-4. PubMed ID: 955132 [TBL] [Abstract][Full Text] [Related]
8. Effect of estrogen treatment for one year on carbohydrate and lipid metabolism in women with normal and abnormal glucose tolerance test results. Glucose, insulin, growth hormone, triglycerides, and Premarin. Spellacy WN; Buhi WC; Birk SA Am J Obstet Gynecol; 1978 May; 131(1):87-90. PubMed ID: 206144 [TBL] [Abstract][Full Text] [Related]
9. Lipid and carbohydrate metabolic studies after one year of megestrol acetate treatment. Spellacy WN; Newton RE; Buhi WC; Birk SA Fertil Steril; 1976 Feb; 27(2):157-61. PubMed ID: 1248663 [TBL] [Abstract][Full Text] [Related]
10. Blood glucose, insulin, cholesterol and triglyceride levels in women treated for six months with the weekly oral contraceptive R2323. Spellacy WN; Mahan CS; Buhi WC; Dumbaugh VA; Birk SA Contraception; 1978 Aug; 18(2):121-6. PubMed ID: 249676 [TBL] [Abstract][Full Text] [Related]
11. Metabolic effects of a combination of dl-norgestrel and ethinylestradiol in humans. Gerhards E; Lachnit U; Gaude R; Schillinger E Arzneimittelforschung; 1973 Jun; 23(6):779-84. PubMed ID: 4740760 [No Abstract] [Full Text] [Related]
12. The effect of lynestrenol and norethindrone on the carbohydrate and lipid metabolism in subjects with gestational diabetes. Pyörälä T; Vähäpassi J; Huhtala M Ann Chir Gynaecol; 1979; 68(2):69-74. PubMed ID: 507743 [TBL] [Abstract][Full Text] [Related]
13. The effect of sequential oral contraceptive pill (Fysioquens) administration on carbohydrate and lipid metabolism. Vähäpassi J; Pyörälä T Ann Chir Gynaecol; 1979; 68(2):75-81. PubMed ID: 507744 [TBL] [Abstract][Full Text] [Related]
14. Glucose, cholesterol and triglyceride levels in "normal" women during one year of use of an inert intrauterine device. Spellacy WN; Buhi WC; Birk SA J Reprod Med; 1981 May; 26(5):247-9. PubMed ID: 7252937 [TBL] [Abstract][Full Text] [Related]
15. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives. Spellacy WN Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):732-4. PubMed ID: 7039318 [TBL] [Abstract][Full Text] [Related]
16. The effects of a once-a-week steroid contraceptive (R2323) on lipid and carbohydrate metabolism in women during three months of use. Spellacy WN; Buhi WC; Dumbaugh VA; Birk SA Fertil Steril; 1978 Sep; 30(3):289-92. PubMed ID: 710600 [TBL] [Abstract][Full Text] [Related]
17. Glucose and insulin levels during treatment with a combined oral contraceptive agent. Larsson-Cohn U Acta Soc Med Ups; 1971; 76(5-6):223-7. PubMed ID: 5141078 [No Abstract] [Full Text] [Related]
18. Effect of low-dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: results of a controlled, randomized, prospective study. Kjos SL; Shoupe D; Douyan S; Friedman RL; Bernstein GS; Mestman JH; Mishell DR Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1822-7. PubMed ID: 2256489 [TBL] [Abstract][Full Text] [Related]
19. Recognition of borderline carbohydrate-lipid metabolism disturbance: an incipient form of type IV hyperlipoproteinemia? Bassett DR; Block WD; Dean EN; White AA J Cardiovasc Pharmacol; 1990; 15 Suppl 5():S8-17. PubMed ID: 1694936 [TBL] [Abstract][Full Text] [Related]
20. Intravenous glucose tolerance, insulin response, fasting blood glucose and serum insulin during short-term administration of a combined oral contraceptive. Nielsen FH Acta Obstet Gynecol Scand; 1972; 51(4):319-24. PubMed ID: 4642718 [No Abstract] [Full Text] [Related] [Next] [New Search]